CO73 Amivantamab Versus Real-World Clinical Practice in Europe and the US for Patients With Advanced Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations
| Autor: | Chouaid, C, Girard, N, Kron, A, Scheffler, M, Knott, C, Bosquet, L, Trigo, J, Viteri, S, Sebastian, M, Popat, S, Rahhali, N, Toueg, R, Rodrigues, B, Diels, J, Schioppa, CA, Cabrieto, J, Sermon, J, Perualila, NJ, Erdmann, N, Mielke, J, Nematian-Samani, M, Pfaira, I, Martin-Fernandez, C, Mahadevia, P, Li, T, Pick-Lauer, C, Adamczyk, A, Penton, J, Wolf, J |
|---|---|
| Zdroj: | In Value in Health December 2022 25(12) Supplement:S32-S32 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect